ARCHIVES

FDA News: Zydelig approved in three B-cell blood cancers

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Seattle Cancer Care Alliance Marks its 10th Anniversary—January 2011

June 28, 2021

Stop Cancer Changes Leaders, Focus, Sends $1.6M To NCI

August 30, 1991

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

September 15, 2006

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

October 31, 2014

Sept. Is AMA’s Month of Women In Medicine

September 10, 1993

NAB Report To President Makes Pitch for Money, Cites Research Progress

August 9, 1974